Seems like you are coming from United States
Do you want to visit our website in your country
Go to English (US)

Revolutionising Asthma Patient Care: Bedfont Scientific Grant Case Study

Learn how Grantify helped Bedfont Scientific secure a £281,953 Innovate UK medtech grant to fast-track its remote FeNO asthma medical device.

Our client, Bedfont Scientific Ltd., won £281,953 in Innovate UK grants with the help of Grantify’s Funding Experts.

Bedfont leveraged these crucial funds to accelerate its innovation journey and expedite product readiness for its medical device. As world leaders in breath analysis, this innovation centres on FeNO testing, a simple, non-invasive biomarker that measures airway inflammation to help diagnose and monitor asthma.

Company

Bedfont Scientific Ltd

Industry

Medtech

Service

Innovate UK Smart Grant

Quick Summary

£281,953

Secured in non-dilutive funding

Challenge

Asthma requires ongoing monitoring, but in-person testing limits effective care.

  • Low patient adherence and engagement
  • No real-time clinical insights
  • Higher costs and delayed treatment adjustments

Solution

Bedfont enables remote FeNO testing for simple, at-home asthma monitoring.

  • Non-invasive biomarker measuring airway inflammation
  • Guides personalised treatment and predicts flare-ups
  • Continuous, convenient monitoring for patients

Impact

A £281,953 Innovate UK Smart Grant accelerated Bedfont’s R&D and market readiness.

  • Faster route to market, improving competitiveness
  • Greater patient engagement and reduced clinic visits
  • Proactive, personalised asthma care with better outcomes and lower costs

Introduction to Bedfont Scientific Ltd

Bedfont Scientific Ltd. is a family-run medical technology company, founded in 1976. It specialises in designing and manufacturing breath analysis medical devices, ranging from portable to benchtop instruments, used in healthcare, diagnostics, pharmaceuticals, and more.

The Challenge

Bedfont recognised the importance of balancing its commitment to innovation with the need to access external funding. Rather than diverting internal resources away from research and development, the company made a strategic decision to partner with specialists to manage the grant application process.

This collaboration ensured that funding opportunities were pursued with precision while allowing Bedfont’s teams to remain fully focused on advancing their technology. By streamlining the process in this way, the company was able to accelerate progress, secure vital funding, and maintain momentum without additional strain on internal capacity.

Grantify: Simplifying the Grant Application Process

A screenshot of the Grantify platform

Tailored Application Strategy

An orange circle with a white check mark, serving as a bullet point

Identified the best grant opportunities for the project

An orange circle with a white check mark, serving as a bullet point

Developed a structured technical innovation story

An orange circle with a white check mark, serving as a bullet point

Built a compelling business case

A screenshot of the Grantify platform

Expert support

An orange circle with a white check mark, serving as a bullet point

Provided a dedicated grant specialist

An orange circle with a white check mark, serving as a bullet point

Offered technical writing assistance

An orange circle with a white check mark, serving as a bullet point

Guided detailed budget preparation

A screenshot of the Grantify platform

Tailored Application Strategy

An orange circle with a white check mark, serving as a bullet point

Established a clear application timeline

An orange circle with a white check mark, serving as a bullet point

Conducted regular progress reviews

An orange circle with a white check mark, serving as a bullet point

Performed quality assurance checks

“As a highly innovative company, we wanted to keep our focus on research and development while also securing funding to accelerate what we believe to be the next major breakthrough. To achieve this, we chose to outsource our grant writing. 

“This approach enabled us to navigate complex funding requirements more effectively, freeing our Research & Development teams to concentrate on core innovation. As a result, we have successfully secured funding and accelerated progress without additional administrative burden.”

Hannah Vince-Drew
Clinical & Medical Affairs Manager

The Impact

With Grantify’s support in navigating the application, Bedfont secured a £281,953 Innovate UK award that enabled the fast-tracking of its remote FeNO testing solution. This non-invasive technology measures airway inflammation, helping clinicians guide treatment and anticipate asthma exacerbations. By bringing testing into patients’ homes, it empowers individuals to stay engaged with their care while providing clinicians with continuous, real-time data to make proactive, personalised decisions. 

The funding not only shortened R&D timelines and accelerated product readiness but also positioned Bedfont to enter the market faster, enhancing its competitiveness and delivering meaningful improvements in patient outcomes and healthcare efficiency.

What’s Next for Bedfont Scientific Ltd?

Bedfont is committed to pushing the boundaries of innovation and has ambitious plans to secure further grant funding to fuel its research and development. Building on its success, the company will pursue additional Innovate UK opportunities to accelerate both existing projects and new breakthroughs, ensuring it remains at the forefront of medical device innovation and long-term growth.

“Innovate UK SMART grants are among the most competitive funding awards in the UK, with applications reviewed by independent experts. Winning this grant is a strong endorsement of our innovation, strategy, and team, and it highlights the impact our work can deliver. This recognition helps raise our profile, reinforcing Bedfont’s position as a leader in the breath analysis medical device field.”

Hannah Vince-Drew
Clinical & Medical Affairs Manager

Your Success Story Starts Here

Take our 90-second quiz to see if you could be eligible for funding to fuel your innovation.

Take the Quiz
Seems like you are coming from United Kingdom
Do you want to visit our website in your country
Go to English (UK)

Revolutionising Asthma Patient Care: Bedfont Scientific Grant Case Study

Learn how Grantify helped Bedfont Scientific secure a £281,953 Innovate UK medtech grant to fast-track its remote FeNO asthma medical device.

Our client, Bedfont Scientific Ltd., won £281,953 in Innovate UK grants with the help of Grantify’s Funding Experts.

Bedfont leveraged these crucial funds to accelerate its innovation journey and expedite product readiness for its medical device. As world leaders in breath analysis, this innovation centres on FeNO testing, a simple, non-invasive biomarker that measures airway inflammation to help diagnose and monitor asthma.

Company

Bedfont Scientific Ltd

Industry

Medtech

Service

Innovate UK Smart Grant

Quick Summary

£281,953

Secured in non-dilutive funding

Challenge

Asthma requires ongoing monitoring, but in-person testing limits effective care.

  • Low patient adherence and engagement
  • No real-time clinical insights
  • Higher costs and delayed treatment adjustments

Solution

Bedfont enables remote FeNO testing for simple, at-home asthma monitoring.

  • Non-invasive biomarker measuring airway inflammation
  • Guides personalised treatment and predicts flare-ups
  • Continuous, convenient monitoring for patients

Impact

A £281,953 Innovate UK Smart Grant accelerated Bedfont’s R&D and market readiness.

  • Faster route to market, improving competitiveness
  • Greater patient engagement and reduced clinic visits
  • Proactive, personalised asthma care with better outcomes and lower costs

Introduction to Bedfont Scientific Ltd

Bedfont Scientific Ltd. is a family-run medical technology company, founded in 1976. It specialises in designing and manufacturing breath analysis medical devices, ranging from portable to benchtop instruments, used in healthcare, diagnostics, pharmaceuticals, and more.

The Challenge

Bedfont recognised the importance of balancing its commitment to innovation with the need to access external funding. Rather than diverting internal resources away from research and development, the company made a strategic decision to partner with specialists to manage the grant application process.

This collaboration ensured that funding opportunities were pursued with precision while allowing Bedfont’s teams to remain fully focused on advancing their technology. By streamlining the process in this way, the company was able to accelerate progress, secure vital funding, and maintain momentum without additional strain on internal capacity.

Grantify: Simplifying the Grant Application Process

a screenshot of the Grantify platform

Tailored Application Strategy

An orange circle with a white check mark, serving as a bullet point

Identified the best grant opportunities for the project

Developed a structured technical innovation story

Built a compelling business case

A screenshot of the Grantify platform

Expert support

Provided a dedicated grant specialist

Offered technical writing assistance

Guided detailed budget preparation

A screenshot of the Grantify platform

Tailored Application Strategy

Established a clear application timeline

Conducted regular progress reviews

Performed quality assurance checks

“As a highly innovative company, we wanted to keep our focus on research and development while also securing funding to accelerate what we believe to be the next major breakthrough. To achieve this, we chose to outsource our grant writing. 

“This approach enabled us to navigate complex funding requirements more effectively, freeing our Research & Development teams to concentrate on core innovation. As a result, we have successfully secured funding and accelerated progress without additional administrative burden.”

Hannah Vince-Drew
Clinical & Medical Affairs Manager

The Impact

With Grantify’s support in navigating the application, Bedfont secured a £281,953 Innovate UK award that enabled the fast-tracking of its remote FeNO testing solution. This non-invasive technology measures airway inflammation, helping clinicians guide treatment and anticipate asthma exacerbations. By bringing testing into patients’ homes, it empowers individuals to stay engaged with their care while providing clinicians with continuous, real-time data to make proactive, personalised decisions. 

The funding not only shortened R&D timelines and accelerated product readiness but also positioned Bedfont to enter the market faster, enhancing its competitiveness and delivering meaningful improvements in patient outcomes and healthcare efficiency.

What’s Next for Bedfont Scientific Ltd?

Bedfont is committed to pushing the boundaries of innovation and has ambitious plans to secure further grant funding to fuel its research and development. Building on its success, the company will pursue additional Innovate UK opportunities to accelerate both existing projects and new breakthroughs, ensuring it remains at the forefront of medical device innovation and long-term growth.

“Innovate UK SMART grants are among the most competitive funding awards in the UK, with applications reviewed by independent experts. Winning this grant is a strong endorsement of our innovation, strategy, and team, and it highlights the impact our work can deliver. This recognition helps raise our profile, reinforcing Bedfont’s position as a leader in the breath analysis medical device field.”

Hannah Vince-Drew
Clinical & Medical Affairs Manager

Your Success Story Starts Here

Take our 90-second quiz to see if you could be eligible for funding to fuel your innovation.

Take the Quiz